Aspirin and Preeclampsia

Summary

This is a single-center, double-blind, randomized, placebo-controlled clinical trial. Peripartum and postpartum Activin A are significantly elevated in women with preeclampsia. Our hypothesis is that elevated Activin A levels reflect a remediable signal and that reducing postpartum Activin A levels with aspirin therapy will improve (GLS) in preeclamptic patients.

Timeline

Start

2021-02-15

Primary completion

2026-12-01

Completion

2026-12-31

Drugs

Indications